Beijing Health-Biotech Stem Cell Technology

Beijing Health-Biotech Stem Cell Technology is a Chinese biotechnology company specializing in the research, development, and clinical application of adult stem cell therapies. The company focuses on utilizing mesenchymal stem cells (MSCs) derived from various sources, including umbilical cord and bone marrow, to treat chronic and degenerative diseases. Their primary therapeutic targets include liver cirrhosis, autoimmune disorders like systemic lupus erythematosus, and neurological conditions such as spinal cord injuries. Beijing Health-Biotech operates advanced laboratory facilities for cell processing and maintains collaborations with several major hospitals in China for clinical trials. The company aims to provide standardized, high-quality cell products for regenerative medicine applications.